A Fluorescence-based Assay of Phospholipid Scramblase Activity

Birgit Ploier; Anant K. Menon

doi:10.3791/54635

JoVE Journal > Biochemistry

Biyokimya

A Fluorescence-based Assay of Phospholipid Scramblase Activity

Published: September 20, 2016

doi:

10.3791/54635

Birgit Ploier¹, Anant K. Menon¹

¹Department of Biochemistry,Weill Cornell Medical College

Özet

We describe a fluorescence-based assay to measure phospholipid scrambling in large unilamellar liposomes reconstituted with opsin.

Abstract

Scramblases translocate phospholipids across the membrane bilayer bidirectionally in an ATP-independent manner. The first scramblase to be identified and biochemically verified was opsin, the apoprotein of the photoreceptor rhodopsin. Rhodopsin is a G protein-coupled receptor localized in rod photoreceptor disc membranes of the retina where it is responsible for the perception of light. Rhodopsin's scramblase activity does not depend on its ligand 11-cis-retinal, i.e., the apoprotein opsin is also active as a scramblase. Although constitutive and regulated phospholipid scrambling play an important role in cell physiology, only a few phospholipid scramblases have been identified so far besides opsin. Here we describe a fluorescence-based assay of opsin's scramblase activity. Opsin is reconstituted into large unilamellar liposomes composed of phosphatidylcholine, phosphatidylglycerol and a trace quantity of fluorescent NBD-labeled PC (1-palmitoyl-2-{6-[7-nitro-2-1,3-benzoxadiazole-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine). Scramblase activity is determined by measuring the extent to which NBD-PC molecules located in the inner leaflet of the vesicle are able to access the outer leaflet where their fluorescence is chemically eliminated by a reducing agent that cannot cross the membrane. The methods we describe have general applicability and can be used to identify and characterize scramblase activities of other membrane proteins.

Introduction

The photoreceptor rhodopsin, a prototypical G protein-coupled receptor (reviewed for example in reference ¹), is the first phospholipid scramblase to be identified and biochemically verified ^2,3. Scramblases are phospholipid transporters that increase the intrinsically slow rate of transbilayer phospholipid movement to physiologically appropriate levels in a bidirectional, ATP-independent manner ^4-6. Examples of their actions can be found in the endoplasmic reticulum and bacterial cytoplasmic membrane where constitutive scrambling is needed for membrane homeostasis and growth, as well as for a variety of glycosylation pathways ⁵. Regulated phospholipid scrambling is needed to expose phosphatidylserine (PS) on the surface of apoptotic cells where it acts as an "eat-me"-signal for macrophages ⁷ and provides a procoagulant surface on activated blood platelets to catalyze the production of protein factors needed for blood clotting. In photoreceptor disc membranes, rhodopsin's scrambling activity has been suggested to counteract the phospholipid imbalance between the two membrane leaflets of the bilayer that is generated by the ATP-dependent, unidirectional lipid flippase ABCA4 ^4,8,9^10-12.

Despite the physiological importance of scramblases, their identity remained elusive until rhodopsin was reported as a scramblase in photoreceptor discs ², members of the TMEM16 protein family were identified as Ca²⁺-dependent scramblases needed for PS exposure at the plasma membrane (reviewed in reference ¹³), and the bacterial protein FtsW was proposed as a Lipid II scramblase required for peptidoglycan synthesis ¹⁴. These discoveries were based on the reconstitution of purified proteins in liposomes and demonstration of scramblase activity in the resulting proteoliposomes using the methodology described here. Other potential scramblases ^15-21 — the MurJ and AmJ proteins implicated in peptidoglycan biosynthesis, WzxE and related proteins implicated in scrambling O-antigen precursors, MprF protein needed to translocate aminoacylated phosphatidylglycerol across the bacterial cytoplasmic membrane, and Xkr8 family members that have been proposed to expose PS on the surface of apoptotic cells — remain to be tested biochemically. This highlights the importance of a robust assay to identify and characterize scramblase activity.

Here, we describe the reconstitution of purified opsin, the apoprotein of the photoreceptor rhodopsin, into large unilamellar vesicles (LUVs), and subsequent analysis of scramblase activity in the resulting proteoliposomes using a fluorescence-based assay. There are several well-described protocols available in the literature for the heterologous expression and purification of opsin, therefore we will not describe it in this protocol; we use the protocols described in Goren et al. ³ which yields FLAG-tagged, thermostable opsin at about 100 ng/µl in 0.1% (w/v) dodecylmaltoside (DDM).

Reconstitution is achieved by treating LUVs with sufficient detergent so that they swell but do not dissolve. Under these conditions, a membrane protein — supplied in the form of protein-detergent micelles — will integrate into the liposomes and become reconstituted into the liposome membrane upon detergent removal, resulting in proteoliposomes. To reconstitute opsin (obtained as a purified protein in 0.1% (w/v) DDM), LUVs are prepared from a mixture of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]) and saturated with DDM before adding opsin and NBD-PC. The detergent is then removed by treating the sample with polystyrene beads.

The principle underlying the fluorescence-based assay is shown in Figure 1B. LUVs are symmetrically reconstituted with a trace amount of NBD-PC or other NBD-labeled fluorescent phospholipid reporter (Figure 1A). On adding dithionite, a membrane-impermeant dianion, NBD-PC molecules in the outer leaflet of the LUVs are rendered non-fluorescent as the nitro-group of NBD is reduced to a non-fluorescent amino-group. As neither NBD-PC molecules nor dithionite are able to traverse the membrane on the time-scale of the experiment (<10 min), this results in 50% reduction of the fluorescent signal. However, if the liposomes are reconstituted with a scramblase, NBD-PC molecules in the inner leaflet can scramble rapidly to the outside where they are reduced. This results in the total loss of fluorescence in the ideal case (Figure 1C).

Figure 1: Schematic representation of the scramblase activity assay. The assay uses a fluorescent NBD-labeled reporter lipid; NBD-PC is shown (A). Large unilamellar vesicles are reconstituted with a trace amount of NBD-PC. Reconstitution produces symmetric vesicles, with NBD-PC distributed equally in the outer and inner leaflets. Dithionite (S₂O₄^2-) chemically reduces the nitro-group of NBD to a non-fluorescent amino-group. Treatment of protein-free liposomes with dithionite (B, top) causes a 50% reduction of fluorescence since only the NBD-PC molecules in the outer leaflet are reduced: dithionite is negatively charged and cannot cross the membrane to react with NBD-PC molecules in the inner leaflet. Dithionite treatment of opsin-containing proteoliposomes (B, bottom), i.e., scramblase-active proteoliposomes, results in 100% loss of fluorescence as opsin facilitates movement of NBD-PC between the inner and the outer leaflet. (C) shows idealized fluorescence traces obtained on treating protein-free liposomes and opsin-containing proteoliposomes with dithionite. The rate of fluorescence loss is the same in both cases indicating that the chemical reduction of NBD by dithionite is rate-limiting, and that scrambling occurs at a rate equal to or greater than the rate of the chemical reaction. Traces obtained from an actual experiment are shown in Figure 3. Please click here to view a larger version of this figure.

The methods we describe can be used to reconstitute and assay other purified proteins, as well as mixtures of membrane proteins obtained, for example, by extracting microsomes with detergent ²².

Protocol

1. Preparation of Liposomes and Proteoliposomes

Liposome Formation
1. Using a glass syringe, add 1,435 µl POPC (25 mg/ml, in chloroform) and 160 µl POPG (25 mg/ml, in chloroform) to a round bottom flask to obtain 52.5 µmol lipids in a molar ratio of POPC:POPG = 9:1.
2. Dry the lipids for 30 min using a rotary evaporator at a rotation speed of 145 rpm (no water bath is needed for this volume of solvent), then transfer the flask to a vacuum desiccator for at least 3 hr, or overnight, at room temperature (RT).
3. Hydrate the dried lipid film with 10 ml of 50 mM HEPES pH 7.4, 100 mM NaCl (henceforth referred to as buffer A) by gently swirling the flask until a homogenous, turbid suspension results;
  NOTE: The lipid concentration at this stage is expected to be 5.25 mM as no losses should have occurred so far.
4. Sonicate the suspension in a water bath for 10 min at room temperature with a frequency of 40 kHz. The solution will look somewhat clearer.
5. Using an extruder, pass the suspension 10 times through a membrane with a 400 nm pore size, followed by a second cycle of extrusion with 4 passes through a membrane with a 200 nm pore size.
  NOTE: The mean diameter of the resulting LUVs is ~175 nm. If necessary, the size and homogeneity of the LUVs can be checked by Dynamic Light Scattering according to the manufacturer's instructions.
6. Quantify the phospholipid concentration of the LUV suspension as described in section 1.2).
  NOTE: Because of losses during extrusion, the concentration is usually around 3.6 mM.
7. Store the LUVs at 4 °C for about 2 weeks if not used immediately.
Phospholipid Quantification
NOTE: To determine the phospholipid concentration of the LUV suspension used for reconstitution, as well as that of the proteoliposomes that are eventually generated, an aliquot of the sample is subjected to oxidation by perchloric acid. This procedure breaks down phospholipids to release inorganic phosphate that is then quantified by a colorimetric assay in comparison with standards ²³.
1. Prepare a 40 mM stock solution of sodium phosphate (Na₂HPO₄) in deionized distilled water.
2. Dilute the stock solution with deionized distilled water to obtain 4 mM and 0.4 mM working solutions that will serve as calibration standards.
3. Using the working solutions, prepare standards in 13 x 100 mm² glass tubes ranging from 0 to 80 nmol sodium phosphate in a final volume of 50 µl.
4. Take 10 µl each of the LUV and proteoliposome samples to be quantified and dilute with 40 µl of ddH₂O in 13 x 100 mm² glass tubes.
  NOTE: As the lipid concentration of the LUVs and proteoliposomes is in the range 2.5-5 µM, the 10 µl of sample should contain 25-50 nmol lipid phosphorus.
5. Add 300 µl perchloric acid to each of the standards and samples and heat for 1 hr at 145 °C in a heating block. Put marbles on the tubes to prevent evaporation.
6. Let the tubes cool to room temperature and add 1 ml of ddH₂O.
7. Add 400 µl each of freshly prepared 12 g/L ammonium molybdate and 50 g/L sodium ascorbate and vortex to mix.
8. Heat for 10 min at 100 °C with marbles on top of the tubes. Remove the tubes from the heating block and let them cool to room temperature.
9. Measure the absorbance of the samples against the blank (standard sample containing 0 nmol sodium phosphate) with a spectrometer at a wavelength of 797 nm.
10. Determine the phosphate content of samples against the calibration standard curve.
Reconstitution of Opsin
NOTE: It is necessary to determine optimal swelling conditions for reconstitution as these depend on the nature of the detergent, as well as the lipid composition and concentration of the LUVs. As LUVs change their light scattering properties on swelling the process can be monitored by measuring absorbance (Figure 2) as reviewed by Rigaud and Levy ²⁴ and Geertsma et al. ²⁵.
1. Pipette 800 µl of LUVs (from section 1.1; as lipid recovery after extrusion is 70%, the expected concentration of LUVs is 3.6 mM phospholipid) into a 2 ml microfuge tube.
2. Add 5.3 µl of buffer A and 34.7 µl of 10% (w/v) DDM dissolved in buffer A.
3. Incubate for 3 hr at room temperature with end-over-end mixing.
4. Meanwhile prepare the polystyrene beads:
  1. Use 400 mg of beads per sample and weigh them out in a glass beaker.
  2. Wash them twice with methanol, three times with water and once with buffer A. For each washing step use 5 ml of liquid and stir slowly for 10 min.
    NOTE: It is recommended to prepare the polystyrene beads for several samples at once, e.g., weigh in 6 g of beads and wash with 75 ml of liquid. Excess beads can be stored in a refrigerator for several days.
5. During the last 30 min of vesicle destabilization dry the NBD-labeled phospholipid in a screw-cap glass tube ('reconstitution glass tube'): Per sample, 9.5 µl of NBD-PC (1 mg/ml in chloroform, yielding 0.4 mol% of total phospholipids) are dried under a stream of nitrogen in a glass tube and subsequently dissolved in 45 µl of 0.1% (w/v) DDM in buffer A.
6. After 3 hr of vesicle destabilization add the dissolved-NBD-labeled phospholipid, the DDM-solubilized protein and buffer A such that the final volume of 1 ml contains 0.36% (w/v), i.e., 7 mM, DDM.
  1. Thus, to generate protein-free liposomes (used as a control sample) add 45 µl of NBD-PC (dissolved in 0.1% DDM), 60 µl of 0.1% DDM and 55 µl of buffer A; for proteoliposomes add, for example, 40 µl of protein (from a typical stock solution of ~110 ng/µl) in 0.1% DDM, 45 µl of NBD-PC (dissolved in 0.1% DDM), 20 µl of 0.1% DDM and 55 µl of buffer A.
    NOTE: The order of addition should be as listed.
7. Mix the sample for an additional hr end over end at room temperature.
8. Add 80 mg of the prepared polystyrene beads and incubate the sample with end-over-end mixing for 1 hr at RT.
9. Next add an additional 160 mg of polystyrene beads and incubate with end-over-end mixing for a further 2 hr at RT.
10. Transfer the sample (leaving the spent polystyrene beads behind) to a glass screw-cap tube containing 160 mg of fresh polystyrene beads and mix overnight at 4 °C.
  NOTE: The easiest way to transfer the sample and avoid sucking up beads is to use a Pasteur pipette that is pushed to the bottom of the glass tube with a little positive pressure. Once the tip of the pipette is firmly at the bottom of the tube, then the sample can be withdrawn easily without interference from the beads.
11. The next morning, transfer the sample to a microfuge tube without carrying over beads and place on ice in preparation for the scramblase activity assay.

2. Scramblase Activity Assay

NOTE: The fluorescence intensity of liposomes or proteoliposomes diluted with buffer A is monitored over time upon the addition of dithionite in a fluorescence spectrometer. To obtain a stable starting intensity, the fluorescence is recorded for at least 50 sec (or until a stable signal is achieved) before adding dithionite to a constantly stirred sample and is then followed for at least 500 sec after adding dithionite.

Add 1,950 µl of buffer A to a plastic cuvette containing a mini stir-bar.
Add 50 µl of the prepared proteo(liposomes) and let the sample equilibrate in the fluorescence spectrometer with constant stirring for several sec.
Meanwhile prepare a solution of 1 M dithionite in 0.5 M unbuffered Tris (e.g., for two samples weigh out 20 mg of dithionite in a microfuge tube and dissolve in 114 µl ice-cold 0.5 M Tris directly before use and keep on ice for the next sample).
NOTE: The dithionite solution must be prepared freshly and should not be used more than 20 min after preparation; if many measurements are to be made, aliquots of dithionite can be weighed out in advance and dissolved right before use.
Start the fluorescence monitoring (excitation 470 nm, emission 530 nm, slit width 0.5 nm).
Add 40 µl of the 1 M dithionite solution to the cuvette 50 sec after starting the fluorescence recording (use the septum in the lid of the cuvette chamber if possible) and continue to record the fluorescence for a further 400-600 sec.
Analyze the data as described in section 3.

3. Data Analysis

Kinetics of Scrambling
1. Characterize the fluorescence trace of each sample obtained by the scramblase activity assay by defining the initial fluorescence, F_i, prior to adding dithionite, and the end-point fluorescence, F, reached after >400 sec. F_i is determined for each sample as the mean value of fluorescence for the 30 sec period prior to addition of dithionite.
2. Determine the end-point data corresponding to the extent of fluorescence reduction, R = 100•F/F_i.We use the terms R_L for protein-free liposomes and R_P for opsin-containing proteoliposomes.
Determining the Molecular Weight of the Functionally Reconstituted Scramblase
1. Convert the fluorescence reduction data according to the following equation:
  p(≥1 scramblase) = (R_P − R_L)/(R_max − R_L) (Equation 1)
  NOTE: Where R_max is the maximum reduction that is obtained when sufficient protein is reconstituted such that all vesicles in the sample possess at least one functional scramblase, and p is the probability that a particular vesicle in a reconstituted sample is 'scramblase-active', i.e., it possesses at least one functional scramblase. The value for R_L is typically 45% ³ whereas R_max is typically 82.5% ³ , instead of the expected 100% (R_max can be experimentally determined for opsin proteoliposomes with a PPR of >1 mg/mmol). As R_max <100% it is assumed that a sub-population of vesicles is refractory to reconstitution. For R_max = 82.5%, the fraction of vesicles that is unable to accept protein is 0.35.
2. Describe the relationship between p(≥1 scramblase) and PPR (mg protein/mmol phospholipid) by Poisson statistics as follows:
  p(≥1 scramblase) = 1 – e^-m = 1 – exp(-PPR/α) (Equation 2)
  NOTE: Where m = number of scramblases per vesicle and α = mono-exponential fit constant in units of mg protein/mmol phospholipid.
3. As a fraction of the vesicles does not contribute to scrambling even at high PPR (see discussion), modify the equation to:
  p(≥1 scramblase) = 1 – exp(-PPR*/α) (Equation 3)
  NOTE: Where PPR* = PPR/(1-f), where f is the refractory population of vesicles or, in this case, PPR* = PPR/0.65 (Equation 4).
  NOTE: The fit constant α is determined by fitting a graph of p(≥1 scramblase) versus PPR* with a mono-exponential function. If opsin (molecular weight 41.7 kDa) functionally reconstitutes into 175-nm-diameter vesicles (each vesicle has 280,000 phospholipids ²⁶) as a monomer, α = 0.187 mg mmol⁻¹. If opsin dimerizes prior to reconstitution ³ to yield scramblase-active vesicles, then α = 0.37 mg mmol⁻¹. If PPR rather than PPR* were to be used for the analysis, then the corresponding α values would be 0.122 and 0.244 mg mmol⁻¹. These predicted values for α assume that all opsin molecules are functionally competent. If only a fraction of the molecules is competent to scramble lipids, then the corresponding values of α will be larger.

Representative Results

We describe the reconstitution of opsin into LUVs to characterize its scramblase activity using a fluorescence-based assay. We analyze the results to place a lower limit on the rate of opsin-mediated phospholipid scrambling and to determine the oligomeric state in which opsin functionally reconstitutes into the vesicles.

To identify optimal reconstitution conditions, it is necessary to determine empirically the amount of detergent that must be used to swell the LUVs so that they are receptive to protein insertion. Such an experiment is illustrated in Figure 2A. Aliquots of POPC:POPG LUVs are treated with different amounts of DDM for 3 hr and the absorbance of the sample is measured at 540 nm, a measure of turbidity and therefore of vesicle size. The optical density measured at 540 nm (OD₅₄₀) graph shows that the vesicles swell as DDM concentration is increased from 4-6 mM, reach a saturation point at around 7 mM before starting to solubilize (corresponding to loss of turbidity and OD₅₄₀ signal) as DDM is increased further. NBD-PC is added after the detergent treatment and the samples are further incubated for an hour before being treated with polystyrene beads to remove detergent. The transbilayer distribution of NBD-PC is determined by measuring fluorescence loss after adding dithionite to the vesicles (as described above). Thus, NBD-PC inserts into the outer leaflet of vesicles in the absence of detergent, indicated by its complete accessibility to dithionite. For vesicles treated with >2 mM DDM, NBD-PC is able to distribute symmetrically into both leaflets so that once DDM is removed 50% of the NBD-PC is protected from dithionite.

Figure 2B shows a similar destabilization-reconstitution experiment (redrawn from reference ²), this time tracking the reconstitution of opsin. In this experiment it can be seen that 7 mM DDM is needed for opsin reconstitution such that NBD-PC becomes quantitatively (>80%) accessible to dithionite as a result of opsin-mediated scrambling.

Figure 2: Reconstitution of NBD-PC and opsin into detergent-destabilized vesicles. (A) Aliquots of the vesicles are treated with a range of detergent concentrations (0-9 mM) by mixing end-over-end for 3 hr at room temperature. At the end of the incubation period the absorbance of the samples at 540 nm is measured (black line). NBD-PC (dissolved in 0.1% w/v DDM) is then added and the sample is incubated for a further 1 hr at room temperature before the detergent is removed by polystyrene beads treatment. The resulting liposomes are analyzed by the fluorescent reduction assay (red line) to determine the extent to which NBD-PC is symmetrically reconstituted. (B) As in (A) but in this experiment vesicles formed from egg phospholipids (egg PC/egg phosphatidic acid, 9:1 mol/mol) were destabilized with DDM, and opsin was added together with NBD-PC, resulting in a fluorescence reduction of about 80% once the protein is efficiently reconstituted and able to facilitate scrambling of NBD-PC (modified from reference ²). Although NBD-PC was symmetrically reconstituted at 2 mM DDM, the ideal conditions for reconstituting opsin were chosen around the peak of OD₅₄₀ absorbance, i.e., the point where the vesicles were highly swollen due to intercalated detergent but not yet solubilized (indicated by the arrow). For POPC/POPG (9:1 mol/mol) vesicles, a DDM concentration of 8 mM was found to be optimal for both NBD-PC and opsin reconstitution. Please click here to view a larger version of this figure.

The extent of fluorescence reduction increases with the amount of opsin used for reconstitution. Figure 3A shows fluorescence traces obtained on adding dithionite to NBD-PC-containing protein-free liposomes (black trace) and proteoliposomes reconstituted with opsin at different protein to phospholipid ratios (PPR, in units of mg protein per mmol phospholipid, red traces); the traces have been normalized so that they all have the same initial fluorescence (F_i) value for easier visualization. Monoexponential fits of the traces indicate very similar time constants, ranging from 20-25 sec; as the rate of dithionite-mediated NBD-PC reduction in protein-free liposomes is the same as in the proteoliposomes, it is only possible to place a lower estimate on the rate of opsin-mediated scrambling (see text for more details). Figure 3B shows the analyzed data obtained from the fluorescence reduction assays to yield plots of p (≥1) scramblase (the probability of a vesicle having at least one scramblase) versus the experimentally measured PPR (related to PPR* as discussed above). Comparison of the monoexponential fit of the experimental results in hypothetical fits corresponding to opsin being reconstituted as a monomer, dimer or tetramer show that opsin reconstitutes functionally as a dimer.

Figure 3: Scramblase activity of opsin. (A) Fluorescence traces corresponding to dithionite treatment of vesicles reconstituted with NBD-PC and opsin amounts ranging between 0-4.95 µg, indicated by the wedge. The lowest amount of opsin reconstituted corresponds to a PPR of 0.21 mg/mmol, the second highest amount to 0.43 mg/mmol and the highest amount to 1.3 mg/mmol, or 10 opsins per vesicle on average. Dithionite was added at the indicated time (arrow) and NBD fluorescence was monitored for a further 400 sec. The maximum extent of fluorescence reduction seen in this experiment was 85% whereas the average over many experiments is 82.5%. (B) Protein dependence of scrambling. Data from experiments similar to panel A were analyzed using Poisson statistics to generate a graph of the probability of vesicles having at least one scramblase (p ≥1 scramblase) versus the protein to phospholipid ratio (PPR) of the vesicles (protein was quantified post-reconstitution by Western Blot analysis ³ and phospholipid was determined by measuring inorganic phosphate released upon acid hydrolysis). The red line represents a mono-exponential fit for the data; the dashed grey lines represent mono-exponential fits for reconstitution of opsin into 170 nm-diameter vesicles as monomers, pre-formed dimers or pre-formed tetramers. As the x-axis represents the experimentally measured PPR (rather than PPR* (see main text)), the fit constants correspond to PPR rather than PPR* values, as discussed in the main text. Please click here to view a larger version of this figure.

Discussion

The scramblase activity assay enabled us originally to determine that opsin has phospholipid scramblase activity ². The assay also allowed us to characterize opsin's scramblase activity by testing specificity (we used a variety of NBD-labeled reporter lipids such as NBD-phosphatidylethanolamine, labeled with NBD on an acyl chain as shown for NBD-PC in Figure 1A, or on the headgroup, NBD-sphingomyelin or NBD- phosphatidylserine ²), the effect of vesicle lipid composition (e.g., cholesterol at different amounts as vesicle constituent), and whether the different conformational states of opsin and rhodopsin all exhibit scramblase activity. These analyses revealed that rhodopsin's scramblase activity is very fast (>10,000 phospholipids per sec), non-specific for the phospholipid and independent of rhodopsin's conformational state or whether or not it contains its chromophore retinal ^2,3. Here, we presented a detailed method to generate proteoliposomes containing opsin and showed how to assay these preparations for phospholipid scramblase activity.

The described reconstitution protocol is optimized for the given lipid composition and for reconstituting opsin after it was purified by affinity chromatography using DDM as solubilizing detergent. The lipid composition as well as the detergent can be changed according to the needs of the experimenter, although the ideal reconstitution conditions for altered conditions have to be determined by performing the "swelling-experiment" described in Figure 2. DDM is empirically well-suited for maintaining opsin in stable and active condition. However, other detergents such as octyl-β-glucoside, CHAPS or Triton X-100 can be used following similar protocols. Triton X-100 is a widely used detergent for reconstituting ATP-binding cassette transporters (ABC transporters) as its efficiency in mediating membrane reconstitution is higher than of other detergents and it also takes less time to equilibrate with preformed liposomes ²⁴.

It is possible to determine the oligomeric state of the functionally reconstituted opsin if the extent of fluorescent reduction is obtained for samples reconstituted with different amounts of opsin, i.e., over a range of protein to phospholipid ratios (PPRs). In order to do this, the PPR of the reconstituted vesicles must be explicitly measured as recovery of protein and phospholipid may vary. Phospholipid recovery can be determined by the phosphate assay described in section 1.2, while protein recovery can be estimated by quantitative Western Blot analysis in which the purified proteins used for reconstitutions are used to generate a calibration curve that allows comparison to the recovery of reconstituted samples across the PPR range tested (as explained in detail in reference ³).

The scramblase activity assay is built on the assumption that dithionite does not permeate into the vesicles. This point can be verified by trapping a soluble NBD-labeled reporter within the vesicles and determining whether it can be reduced by dithionite. For this purpose, NBD-glucose (12.6 µM added after vesicle destabilization) is used instead of NBD-PC. This water-soluble molecule is trapped within the proteoliposomes once the vesicles are sealed and should therefore be protected from dithionite. To make the NBD-glucose fully accessible for reduction, Triton X-100 can be added (1% w/v) which then results in 100% reduction ^3,27.

The proteoliposomes can be characterized to verify that reconstitution of both the reporter lipid and protein is symmetric. The former is achieved by collisional quenching experiments using iodide ions while the latter is based on a protease protection strategy using AspN protease that cuts at a specific site near the C-terminus of opsin ³.

The transition from the initial fluorescence (F_i) determined in the scramblase activity assay to the end-point fluorescence (F) is complex, but for our purposes it can be reasonably approximated by a single exponential decay function. The time constant associated with the exponential decay (20 sec) is roughly the same for inactive liposomes and active, opsin-containing proteoliposomes indicating that scrambling occurs as fast, or faster than the rate at which the NBD fluorophore is reduced by dithionite. Thus the scramblase activity assay has a poor time resolution (limited by dithionite reduction chemistry) which currently only permits classification of mutants into active, very slow or inactive. This classification could be seen for the calcium-regulated scramblase TMEM16 ²⁷: at high Ca²⁺ levels, the fluorescence decay revealed a time constant similar to that seen in protein-free liposomes, indicating that the rate limiting step is the chemical reduction of the NBD-fluorophore by dithionite than lipid scrambling. On the contrary, at low Ca²⁺ levels the steady state of fluorescent reduction was not reached after 900 sec, making it possible to distinguish between two kinetic components, one assigned to the dithionite reduction of the outer leaflet and the slower one to the exposure of inner-leaflet NBD-lipids to the outside.

The discrepancy between the predicted 100% loss of fluorescence on dithionite treatment of vesicles prepared with high PPR (Figure 1C) versus the experimental reality where it is difficult to exceed ~85% reduction (Figure 3A) suggests that a fraction of the vesicles is refractory to reconstitution. This fraction could correspond to vesicles that seal early during the reconstitution procedure as detergent is adsorbed to the polystyrene beads and are therefore no longer able to receive protein. For the analysis described in section 3, we assumed that this refractory population corresponds to a fraction f of the total vesicles. If we assume that half of the NBD-PC molecules (the pool of NBD-PC in the outer leaflet) in the refractory vesicles is available for dithionite reduction, then we estimate f = 2•(1 – R_max/100), or 0.35 when R_max = 82.5%.

Fitting of p(≥1 scramblase) versus PPR* data with a mono-exponential equation provides the fit constant α, from which it is possible to determine whether opsin reconstitutes functionally as a monomer or dimer, or a mixture of states including higher order multimers. The interpretation of these results becomes complicated if a fraction of opsin molecules cannot function in scrambling. While this is unlikely given the conditions under which opsin is purified which guarantee that it retains all of its G protein receptor activities, a value of α corresponding to the functional insertion of dimers could also be interpreted as the functional insertion of monomers from a preparation of opsin where half the proteins are inactive as scramblases. An additional point to consider is that the analysis that we present assumes that the vesicles used for reconstitution are homogeneous in size. In reality, the vesicles have a range of diameters characterized by a Gaussian distribution with a standard deviation corresponding to approximately one third of the mean diameter. Fortunately, the outcome of the analysis of p(≥1 scramblase) versus PPR* data is not significantly affected by consideration of vesicle heterogeneity and so the simple analysis that we presented is sufficient to describe the data.

A potential limitation of the methods that we described is that the work-intensive procedure does not allow high-throughput measurements of a very high number of samples and that vesicle heterogeneity might disturb the readout. The first problem might be overcome by using a microtiter-plate format for the scramblase assay; the second could be solved in the future by single vesicle assays using TIRF microscopy.

The dithionite assay for measuring scramblase activity can be regarded as very reliable and robust once destabilization and reconstitution procedures are established. An alternative approach to quantify transmembrane transport of phospholipids, that also allows verifying results obtained from the dithionite assay, is back-extraction of short-chain NBD-lipids from the outer leaflet of the vesicles using fatty acid-free bovine serum albumin ²². Back-extraction as well as the dithionite assay have also been employed to characterize and identify flippases of the P4-type ATPases and ABC transporters ^28-33.

As the tools presented here can easily be adapted according to different needs the described procedures are versatile and will help in identifying and characterizing phospholipid scramblases in the future. Learning the identity of many of these, including that of the scramblase necessary for the expansion of biogenic membranes during cell growth is of utmost physiological importance.

For additional information and detailed description of data analysis, readers are referred to previous publications from our laboratory ^2-4,27 as well as others ^22,25,28,30.

Açıklamalar

The authors have nothing to disclose.

Acknowledgements

This study was supported by the Velux Stiftung (A.K.M.), NIH grant EY024207 (A.K.M.) and the Austrian Science Fund (FWF) project J3686 (B.P.).

Materials

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	Avanti Polar Lipids	850457C	POPC
1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (sodium salt)	Avanti Polar Lipids	840457C	POPG
1-palmitoyl-2-{6-[7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-an-glycero-3-phosphocholine	Avanti Polar Lipids	810130C	NBD-PC
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid	VWR Scientific	EM-5330	HEPES
NaCl	Sigma	S7653-1KG	NaCl
Dodecyl-β-d-maltoside	Anatrace	D310 5 GM	DDM
Fluorimeter cuvettes	sigma	C0918-100EA	cuvettes
Spectrofluorometer	Photon Technology International, Inc.		fluorimeter
Sodium hydrosulfite technical grade, 85%	Sigma	157953-5G	dithionite
GraphPad Prism 5 software			Prism
Tris Base	VWR	JTX171-3	Tris
LIPEX 10 mL extruder	Northern Lipids, Inc.		Extruder
Whatman, Drain disc, PE, 25 mm	Sigma	28156-243	Disc support
Whatman Nuclepore Track-Etched Membranes, 0.4 µm, 25 mm diameter	Sigma	WHA110607	400 nm membrane
Whatman Nucleopore Track-Etched Membranes, 0.2 µm, 25 mm diameter	Sigma	WHA110606	200 nm membrane
sodium phosphate	Sigma	S3264-500G
VWR Culture Tubes, Disposable, Borosilicate Glass, 13×100 mm	VWR Scientific	47729-572	glass tubes
Perchloric acid	Sigma	30755-500ML
Ammonium Molybdate Tetrahydrate	Sigma	A-7302	ammonium molybdate
(+)-Sodium L-ascorbate	Sigma	A7631-25G	sodium ascorbate
Bio-Beads SM2 adsorbents	Bio Rad	1523920	polystyrene beads
2.0 mL Microtubes clear	VWR Scientific	10011-742	Reconstitution tubes
Reconstitution glass tube	VWR Scientific	53283-800	Reconstitution glass tubes
Zetasizer	Malvern		DLS